Daré Bioscience Stock Is Trading Higher As Bacterial Vaginosis Candidate Secures FDA Priority Review

By: via Benzinga
TheFDA has accepted for reviewDarBioscience Inc's(NASDAQ: DARE) marketing application for DARE-BV1 for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.